Loading data
XBPNasdaq
| Unit: USD | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | 872.69 m USD | — | — | — |
| Gross profit | 188.77 m USD | 39.87 m USD | 43.71 m USD | — |
| Research and development expense | 300 k USD | 900 k USD | 1.1 m USD | — |
| Operating profit | -105.44 m USD | 1.12 m USD | -1.95 m USD | -2.74 m USD |
| Profit before tax | -205.14 m USD | -4.96 m USD | -5.37 m USD | — |
| Income tax expense | 10.01 m USD | 606 k USD | 2.56 m USD | — |
| Net income (reported basis) | -215.15 m USD | -11.05 m USD | -7.93 m USD | -1.71 m USD |
| Net income attributable to common shareholders | -12.37 m USD | -11.05 m USD | — | — |
| Basic earnings per share | 0.41 USD/share | 0.49 USD/share | -0.36 USD/share | — |
| Diluted earnings per share | 0.41 USD/share | 0.49 USD/share | -0.36 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.